Excessive circulating FGF23 acts as a phosphaturic hormone, inducing renalphosphate wasting and inhibiting an appropriate increase in circulating calcitriol,which ultimately leads to hypophosphatemia.1,2 Chronic hypophosphatemia resultsin inadequate bone mineralization and presents clinically as osteomalacia. Here, FGF23 is linked to hypophosphatemia.